The PTMScan Multi-Pathway Service enables the identification and quantification of hundreds of critical signaling nodes across various pathways involved in cancer biology, immune cell signaling, metabolic disease, and more. CST scientists utilize multiplexed cocktails of site- and protein-specific antibodies with LC-MS/MS to cover all of these signaling nodes in a single run.
*The PI3 Kinase/Akt Signaling pathway is just one pathway covered by the PTMScan Direct Multi-Pathway Service.
PTMScan Multi-Pathway Service quantitatively measures a defined set of peptides spanning a large number of signaling pathways, including:
